Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension. [PDF]
Background Pulmonary arterial hypertension (PAH) is a deadly disease without effective non-invasive diagnostic and prognostic testing. It remains unclear whether vasodilators reverse inflammatory activation, a part of PAH pathogenesis.
Kirillova A+12 more
europepmc +4 more sources
Case Report: Acral vasculitis induced by Immune Checkpoint Inhibitors: a case series and literature review. [PDF]
IntroductionImmune Checkpoint Inhibitors (ICIs) may cause various immune- related Adverse Events (irAEs). Of these events, vascular involvement is still considered an uncommon irAEs and generally concerns large or medium vessels.
Rivet V+8 more
europepmc +2 more sources
Age and Vasodilator Response to Different Hyperemic Agents: Adenosine versus Contrast Medium [PDF]
Background: Age-related remodelling has the potential to affect the microvascular response to hyperemic stimuli. However, its precise effects on the vasodilatory response to adenosine and contrast medium, as well as its influence on fractional flow ...
Domenico Galante+18 more
doaj +2 more sources
Vasodilator agents improve hemodialysis vascular access patency: A population-based study from Korea. [PDF]
Kim DH+9 more
europepmc +2 more sources
Loss of response to calcium channel blockers after long-term follow-up treatment in patients with idiopathic pulmonary arterial hypertension [PDF]
Idiopathic pulmonary arterial hypertension (PAH) patients with a positive response to acute vasodilator challenge and a clinical response to calcium channel blockers (CCBs) for at least one year are traditionally designated true responders. Nevertheless,
Bruna Piloto+5 more
doaj +1 more source
Effect of Papaverine on Left Internal Mammary Artery Flow: Topical Spraying versus Perivascular Injection Method [PDF]
Objective: To analyze two techniques of papaverine application, topical spray on the harvested left internal mammary artery (LIMA) and perivascular injection, to find out their ability to improve LIMA flow.
Girish Gowda S L+4 more
doaj +1 more source
Critical care management of pulmonary arterial hypertension in pregnancy: the pre-, peri- and post-partum stages [PDF]
The mortality rate of pulmonary hypertension in pregnancy is 25%–56%. Pulmonary arterial hypertension is the highest incidence among this group, especially in young women.
Vorakamol Phoophiboon+4 more
doaj +1 more source
Background Postischemic cerebral hypoperfusion has been indicated as an important contributing factor to secondary cerebral injury after cardiac arrest. We evaluated the effects of sodium nitroprusside administered via a subdural intracranial catheter on
Hyoung Youn Lee+8 more
doaj +1 more source
Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina
Background Chronic vasodilator therapy with long‐acting nitrate is frequently used to treat vasospastic angina. However, the clinical benefits of this approach are controversial.
Yongwhan Lim+18 more
doaj +1 more source
Intradermal tests with vasomotor agents in chronic non(infectious rhinitis [PDF]
The aim of this prospective study was to examine the skin reactivity to four vasomotor agents in chronic, non-infectious rhinitis patients, and to determine whether non-allergic rhinitis (NAR) patients differ from allergic rhinitis (AR) patients. Seventy
Milošević Dušanka N.+2 more
doaj +1 more source